COMPARING THE EFFICACY OF DRONEDARONE WITH OLDER ANTI-ARRHYTHMIC DRUGS IN PHARMACOLOGICAL ENHANCEMENT OF ELECTRICAL CARDIOVERSION OF ATRIAL FIBRILLATION

被引：0
|
作者：
Ajmal, Muhammad S.
Herle, Aravind
机构：
[1] Mercy Hosp, Buffalo, NY USA
[2] SUNY Buffalo, Catholic Hlth Syst Internal Med Residency Program, Buffalo, NY 14260 USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2012年 / 59卷 / 13期
关键词：
D O I：
10.1016/S0735-1097(12)60689-5
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E688 / E688
页数：1
相关论文
共 50 条
  • [41] Cost Effectiveness of Radiofrequency Catheter Ablation vs. Anti-Arrhythmic Drugs for Paroxysmal Atrial Fibrillation
    Reynolds, Matthew R.
    Ellis, Ethan
    Danilov, Tatyana
    Zimetbaum, Peter
    Josephson, Mark E.
    Cohen, David J.
    CIRCULATION, 2008, 118 (18) : S1164 - S1165
  • [42] AMIODARONE PLUS TYPE-IA ANTI-ARRHYTHMIC DRUGS FOR THE TREATMENT OF REFRACTORY ATRIAL-FIBRILLATION
    BRODSKY, M
    ALLEN, B
    FERGUSON, C
    HENRY, W
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1985, 5 (02) : 480 - 480
  • [43] Stroke Risk in Paroxysmal and Persistent Atrial Fibrillation Treated With Anti-arrhythmic Drugs vs Catheter Ablation
    Mohanty, Sanghamitra
    Trivedi, Chintan G.
    Della Rocca, Domenico G.
    Gianni, Carola
    Bassiouny, Mohammed
    Canpolat, Ugur
    MacDonald, Bryan
    Burkhardt, John D.
    Sanchez, Javier
    Hranitzky, Patrick M.
    Gallinghouse, Joe
    Al-Ahmad, Amin
    Horton, Rodney P.
    Di Biase, Luigi
    Natale, Andrea
    CIRCULATION, 2019, 140
  • [44] Dofetilide: a class III anti-arrhythmic drug for the treatment of atrial fibrillation
    Torp-Pedersen, C
    Brendorp, B
    Kober, L
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2000, 9 (11) : 2695 - 2704
  • [45] The pharmacological management of atrial fibrillation; Is it overshadowing electrical DC cardioversion?
    Mukhtar, Omar
    Pearce, Abigail
    Ray, Kausik
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 70 (02) : 285 - 285
  • [46] CLINICAL AND ECONOMIC OUTCOMES ASSOCIATED WITH USE OF ANTI-ARRHYTHMIC DRUGS VERSUS ABLATION IN ATRIAL FIBRILLATION (AFIB)
    Ken-Opurum, J.
    Vadagam, P.
    Faith, L.
    Srinivas, S. S. S.
    Preblick, R.
    Park, S.
    Charland, S.
    Revel, A.
    VALUE IN HEALTH, 2022, 25 (12) : S98 - S98
  • [47] Arrhythmic complications after electrical cardioversion of acute atrial fibrillation: The FinCV study
    Gronberg, Toni
    Nuotio, Ilpo
    Nikkinen, Marko
    Ylitalo, Antti
    Vasankari, Tuija
    Hartikainen, Juha E. K.
    Airaksinen, K. E. Juhani
    EUROPACE, 2013, 15 (10): : 1432 - 1435
  • [48] STRATEGY OF CARDIOVERSION AND ANTI-ARRHYTHMIC DRUG THERAPY FOR ATRIAL FLUTTER/FIBRILLATION INDUCED TACHYCARDIA MEDIATED CARDIOMYOPATHY - A SINGLE CENTER EXPERIENCE
    Vallurupalli, S.
    Shailesh, F.
    Kasula, S.
    Pant, S.
    Abed, M.
    Paydak, H.
    CARDIOLOGY, 2013, 125 : 334 - 334
  • [49] Comparative risk of dementia among patients with atrial fibrillation treated with catheter ablation versus anti-arrhythmic drugs
    Zeitler, Emily P.
    Bunch, T. Jared
    Khanna, Rahul
    Fan, Xiaozhou
    Iglesias, Maximiliano
    Russo, Andrea M.
    AMERICAN HEART JOURNAL, 2022, 254 : 194 - 202
  • [50] A New Perspective in the Management of Paroxysmal Atrial Fibrillation: Dual Anti-Arrhythmic Medications
    Al-zakhari, Rana
    Mousa, Safa
    Sheets, Nicholas
    Appiah-Kubi, Edmund
    Owusu-Antwi, Philipa
    Isber, Ryan
    Isber, Nidal
    CIRCULATION, 2022, 146
12345